Gian Life Care (BOM:542918) EPS without NRI: ₹-0.94 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542918 Gian Life Care Ltd BOM:542918
61 GF Score
Price ₹4.99
GF Value ₹5.83
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Gian Life Care EPS without NRI?

Gian Life Care BOM:542918 +1.01% 61 EPS without NRI is ₹-0.94 as of Dec. 2025. GuruFocus rates BOM:542918 with a GF Score™ of 61/100 and a GF Value™ of ₹5.83 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 157 Medical Diagnostics & Research companies, Gian Life Care ranks worse than 97.45% on this metric.

Gian Life Care's earnings per share without non-recurring items for the three months ended in Dec. 2025 was ₹0.10. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was ₹-0.94.

During the past 12 months, Gian Life Care's average earnings per share (NRI) Growth Rate was -136.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -77.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -36.80% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Gian Life Care's EPS without NRI or its related term are showing as below:

BOM:542918' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -77.4   Med: -10.2   Max: 27.4
Current: -77.4

During the past 7 years, Gian Life Care's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 27.40% per year. The lowest was -77.40% per year. And the median was -10.20% per year.

BOM:542918's 3-Year EPS without NRI Growth Rate is ranked worse than
97.45% of 157 companies
in the Medical Diagnostics & Research industry
Industry Median: 10.7 vs BOM:542918: -77.40

Gian Life Care's EPS (Diluted) for the three months ended in Dec. 2025 was ₹0.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹-0.94.

Gian Life Care's EPS (Basic) for the three months ended in Dec. 2025 was ₹0.10. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was ₹-0.94.


Gian Life Care  (BOM:542918) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Gian Life Care EPS without NRI Related Terms


Gian Life Care EPS without NRI Historical Data

* Premium members only.

The historical data trend for Gian Life Care's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gian Life Care EPS without NRI Chart

Gian Life Care Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS without NRI
Get a 7-Day Free Trial 1.96 4.23 1.03 4.04 0.05

Gian Life Care Quarterly Data
Sep20 Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 -0.59 0.05 -0.50 0.10

BOM:542918 vs TMO, DHR, IDXX: EPS without NRI Comparison

For the Diagnostics & Research subindustry, Gian Life Care's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gian Life Care PE Ratio without NRI vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Gian Life Care's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Gian Life Care's PE Ratio without NRI falls into.


BOM:542918
61GF Score
Gian Life Care Ltd BOM:542918
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gian Life Care EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of ₹-0.94 mean?
Gian Life Care (BOM:542918) has a EPS without NRI of ₹-0.94 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gian Life Care and its competitors. According to the industry distribution chart, Gian Life Care ranks #153 out of 157 companies in the Medical Diagnostics & Research industry, placing it in the top 97.5%.
Is Gian Life Care's EPS without NRI too high?
Gian Life Care's current EPS without NRI is ₹-0.94. Based on the distribution chart, Gian Life Care ranks #153 out of 157 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Gian Life Care has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Gian Life Care's EPS without NRI compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Gian Life Care ranks #153 out of 157 companies for EPS without NRI. This places Gian Life Care in the lower half of its industry. The industry median EPS without NRI is 10.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Diagnostics & Research company?
The median EPS without NRI among Medical Diagnostics & Research companies is 10.70, based on 157 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Gian Life Care and its competitors. For the Medical Diagnostics & Research industry, the median EPS without NRI is 10.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gian Life Care's current EPS without NRI is ₹-0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gian Life Care stock overvalued right now?
Based on GuruFocus' analysis, Gian Life Care (BOM:542918) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5.83, compared to a current price of ₹4.99 — trading 14.4% below its estimated fair value. The current EPS without NRI is ₹-0.94. Gian Life Care's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Gian Life Care (BOM:542918), the current EPS without NRI is ₹-0.94 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gian Life Care (BOM:542918) Overvalued in 2026?

Based on GuruFocus' analysis, Gian Life Care stock appears to be undervalued. The current stock price of ₹4.99 is trading 14.4% below its estimated GF Value™ of ₹5.83. GuruFocus considers Gian Life Care to be Modestly Undervalued.

Key valuation signals for BOM:542918:

  • EPS without NRI: ₹-0.94
  • GF Value™: ₹5.83 vs. price of ₹4.99 (14.4% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the BOM:542918 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gian Life Care Business Description

Address 7/216 (6) Swaroop Nagar, Infront of L-L.R. Hospital, Kanpur, UP, IND, 208002
Gian Life Care Ltd is an Indian firm engaged in the business of providing diagnostic and related healthcare tests and services in Kanpur and nearby areas. The company provides a broad range of diagnostic and related healthcare tests and services such as patient diagnosis, prevention, and wellness diagnosis services to its patients and healthcare providers. Its customers include individual patients, hospitals, other healthcare providers, and corporate customers. Substantial revenue accrues from the Pathological Testing Fees. The company has only one operating segment namely, Laboratories Pathological Investigations.
61GF Score

Get the complete analysis for BOM:542918

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4.99
Price
₹5.83
GF Value